The UN projects India’s economy to grow at 6.2% in 2024, citing robust domestic demand and sectoral growth. Despite a slight downward revision, the forecast underscores resilience, supported by government spending and supply chain diversification.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale